/FROM PR NEWSWIRE DALLAS 888-776-3971/
IN HEA MTC BIO MEQ
SU PDT LIC
TO BUSINESS, HEALTH, AND MEDICAL EDITORS:
MBL International Corporation Introduces AngioPhaseT Angiogenesis Kit
WOBURN, Mass., Feb. 9, 2012 /PRNewswire/ -- MBL International
Corporation, a leading life science company focused on providing high
quality products and solutions for life science research and clinical
diagnostics, today announced the launch of AngioPhaseT, an
angiogenesis kit which allows for the analysis of all known phases of
the angiogenic process in a convenient and flexible format.
Angiogenesis is the multistep process whereby new blood vessels
develop from pre-existing vasculature. It plays a key role in the
natural process of healing and reproduction but also in many
pathological processes including cancer, skin diseases, age-related
blindness, diabetic ulcers, cardiovascular disease, and stroke.
AngioPhaseT incorporates a patented technology, developed by TCS
Cellworks Limited, Buckingham, UK, in which human endothelial cells
are co-cultured with other human cells in a specially designed medium.
Under the terms of the non-exclusive agreement with TCS Cellworks
Limited, MBL International Corporation has been granted a license to
manufacture and sell the assay in North and South America.
"MBL International is excited about adding AngioPhase to our growing
portfolio of life sciences products," said Dennis Walczewski, CEO MBL
International Corporation. "This technology offers many benefits to
researchers in the biotechnology and pharmaceutical industries by
offering a ready-to-use angiogenesis kit in which test compounds can
be added at any time. Moreover, both angiogenic simulators and
inhibitors can be assessed as well as tubule formation."
"We are pleased to enter into this licensing agreement with MBL
International Corporation," stated Tim Almond CEO of TCS Cellworks.
"They have demonstrated not only a strong commitment to manufacturing
high quality products but also an impressive business model which
leverages the superior technical expertise of their commercial team."
About MBL International Corporation
MBL International Corporation is a leading life science company
focused on providing high quality products and solutions for life
science research and clinical diagnostics. Our products are used
widely in academic research institutions, pharmaceutical and
biotechnology companies, government agencies, as well as hospital and
reference laboratories. By providing a consultative approach, superior
technical and customer support, and convenient purchasing options, MBL
International Corporation is your partner in solving your scientific
and clinical challenges.
For more information visit http://www.mblintl.com or call
About TCS Cellworks Limited
TCS Cellworks is a UK based cellular biology company specializing in
the development and application of human primary cell tissue models
for the bioscience and pharmaceutical business sectors. The success of
the AngioPhase kit in Europe is now being expanded to other markets
through carefully selected business partners. TCS also acts as a
distributor for a number of international manufacturers in the cell
biology field. For further information visit
http://www.tcscellworks.co.uk or call 0044 1280 827475.
SOURCE MBL International Corporation
/CONTACT: Christopher Hargadon, +1-781-939-6964 ext 1107
/Web Site: http://www.mblintl.com
CO: MBL International Corporation; TCS Cellworks Limited
ST: Massachusetts United Kingdom
IN: HEA MTC BIO MEQ
SU: PDT LIC
-- NE50706 --
0000 02/09/2012 16:00:00 EDT http://www.prnewswire.com